-
MiddleBrook expanding promotion of Moxatag through IncreaseRx program
WESTLAKE, Texas MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the drug maker announced Wednesday.
IncreaseRx is a virtual sales-contract organization that gives healthcare professionals access to electronic sampling, learning and education tools. The company has entered an agreement with DoctorDirectory.com, its promotion partner for Moxatag (amoxicillin), and plans to use Web-based educational and promotional tactics to reach prescribers with sales and marketing messages for the drug.
-
Zicam introduces Cold Remedy Plus line
PHOENIX Matrixx Initiatives recently introduced a new line of Zicam products — Cold Remedy Plus, a multi-ingredient formulation that both reduces the duration of the common cold and helps relieve the symptoms of someone who already has a cold.
The Cold Remedy Plus products, cherry-flavored Liqui-Loz and cherry-flavored Zavors, retail for a suggested $11.59. Two mint flavors — including a rapid melt and oral mist — will launch in the fall.